Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,942,983
New position
Shares Held
184,279
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#182
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLENVIEW CAPITAL MANAGEMENT, LLC holds $155,328,104 across 4 Drug Manufacturers - General names. AZN ranks #3 (22.5% of the industry book) .
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,942,983 | 184,279 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||